PEG: Will It Come Back to You? Polyethelyne Glycol Immunogenicity, COVID Vaccines, and the Case for New PEG Derivatives and Alternatives

Affiliations

Yi Wen Kong: David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, United States
Yi Wen Kong: Center for Precision Cancer Medicine, Massachusetts Institute of Technology, Cambridge, MA, United States
Erik C Dreaden: Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, United States
Erik C Dreaden: Department of Pediatrics, Emory School of Medicine, Atlanta, GA, United States
Erik C Dreaden: Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Atlanta, GA, United States
Erik C Dreaden: Winship Cancer Institute of Emory University, Atlanta, GA, United States
Erik C Dreaden: Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA, United States

Abstract

No abstracts available.